SearchDictionaryMobileLogin

Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil.

AbstractWe report a 21-year-old male with childhood-onset familial nephrotic syndrome and frequent relapses who manifested toxicity or treatment resistance to corticosteroids, cyclophosphamide, cyclosporin-A, and tacrolimus. Monotherapy with mycophenolate mofetil (MMF) resulted in maintenance of clinical remission for 14 months without noticeable toxicity, while allowing resolution of steroid-induced side effects. Our observation suggests that MMF may be useful in maintaining remission in nephrotic patients who manifest toxicity to standard immunosuppressive agents.
AuthorsM Chandra, M Susin, C Abitbol (Affiliation: Department of Pediatrics, North Shore University Hospital, New York University School of Medicine, Manhasset 11030, USA.)
JournalPediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 14 Issue 3 Pg. 224-6 (Mar 2000) ISSN: 0931-041X GERMANY
PMID10752763 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • mycophenolate mofetil
  • Mycophenolic Acid
Topics
  • Child, Preschool
  • Drug Resistance
  • Humans
  • Immunosuppressive Agents (adverse effects, therapeutic use)
  • Male
  • Mycophenolic Acid (analogs & derivatives, therapeutic use)
  • Nephrotic Syndrome (drug therapy)
  • Recurrence
  • Remission Induction
  • Retreatment